Advanced Innovative Partners

Advanced Innovative Partners is a private, clinical-stage radiopharmaceutical biotechnology company developing diagnostic and therapeutic theranostic products based on targeted radiation. The company focuses on oncology, rare pediatric diseases, infectious diseases, and biomedical countermeasures, with programs intended to pair molecular imaging and targeted therapeutic payloads for earlier detection and more precise treatment. Its technology approach combines targeting agents such as small molecules or antibodies with radioisotopes for either imaging or therapeutic use. AIP positions itself as a precision-medicine company with a broad but still early and largely undisclosed pipeline rather than a company centered on named late-stage assets. The business appears to be founder-led and based in Florida, with a global-development narrative and emphasis on secure supply chain and collaborative partnerships.